Geronyx blends biotechnology, AI, and genetic research to pioneer next-generation health innovations. From vision restoration to brain aging monitoring and genetic intelligence, we are advancing human longevity.
Our InnovationsGeronyx was founded with a vision to redefine human health and longevity. We integrate cutting-edge biotechnology, artificial intelligence, and genetic research to challenge the boundaries of what is possible. Our mission is to develop life-changing therapies and diagnostics that empower individuals to lead healthier, longer lives.
A breakthrough in amblyopia therapy combining neuroscience, machine learning, and visual stimulation to retrain the brain’s visual pathways.
Capture and monitor brain health via non-invasive brain radio web, building a real-time, AI-powered cognitive longevity platform.
Developing CRISPR and genome-editing platforms aimed at reprogramming genetic code for preventive and therapeutic applications.
Join us in our journey to transform healthcare through data-driven biology. Our flagship products and pipeline hold immense potential to disrupt vision therapy, cognitive health, and genetic therapy markets. Geronyx is poised at the intersection of biotechnology and artificial intelligence.
The global vision therapy market is projected to grow exponentially due to unmet needs in amblyopia treatment and rising awareness of non-invasive neuro-therapy solutions.
The Brain Aging Database taps into the burgeoning field of cognitive health. Our non-invasive monitoring and AI analytics aim to create a new market for preventative brain health solutions.
The Genetic Intelligence Division explores gene-editing therapies poised to revolutionize healthcare. Personalized genomics and CRISPR platforms open possibilities for targeted treatments and preventive care.
Geronyx's success stems from a diverse team of scientists, engineers, and innovators dedicated to revolutionizing human health. Learn more about our leadership and advisors.
Solution Architect with expertise in AI/ML, DevOps, Quantum Computing, and cognitive design. Passionate about immortality and next-gen technologies.
Expert in neuroscience and machine learning, driving the development of OcuveraX and Brain Aging Database initiatives.
Pioneering geneticist focusing on CRISPR applications and genome editing strategies to enhance longevity and prevent disease.
Industry veteran with decades of experience in pharmaceutical development and regulatory affairs.
Renowned AI researcher helping to integrate cutting-edge machine learning into our biotech innovations.
Practicing clinician providing insights on clinical applications and patient outcomes.
We’d love to hear from you! Whether you’re interested in investing or collaboration, please get in touch with us via email.
Email: info@geronyx.com